Objective TNF inhibitors (TNFi) have revolutionised the treating arthritis rheumatoid (RA). patients in clinical remission following a minimum of one year of TNFi therapy (n?=??15); (2) Active RA patients not currently or ever receiving TNFi (n?=?18); and healthy control volunteers (n?=?15). Patients in remission were divided into two groups: those who were preserved on TNFi… Continue reading Objective TNF inhibitors (TNFi) have revolutionised the treating arthritis rheumatoid (RA).